Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

732 public trials 120 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Suspended

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

NCT06639607

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +24 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Suspended

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

NCT04539366

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +20 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details

Related conditions